Answers are grounded in this paper and cite their sources.
Extracellular vesicles (EVs) are recently emerged as biomarkers for cancer diagnosis. RNA in EV specifically has drawn attention for its high stability and accuracy for early cancer diagnosis. However, analysis of EV RNA in plasma for cancer diagnosis often can be limited by a low population of cancer‐derived EVs in the plasma samples. Herein, we developed a sensitive EV RNA analysis technique with protein‐specific EV enrichment for accurate ovarian cancer diagnosis.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: